HRMY Harmony Biosciences Holdings, I
$41.52▲ +1.02%
Healthcare
Other
After hours
$41.52▲ +0.00%
Sep 11, 7:30 PM ET
Volume 973.3K
Avg Volume (10D) 912.1K
Key Metrics & Fundamentals
Market Cap
$2.42B
P/E Ratio
13.4
Div Yield
–%
52W Range
25.52 - 43.49
% vs 50 MA
8.41%
% vs 200 MA
19.65%
RSI-14
58.2
MACD Histogram
+0.0700
Beta (1Y vs SPY)
0.53
Free Cash Flow
$92.43M
Gross Rev
$261.28M
Gross Profit
$198.08M
EBITDA
$102.30M
COGS
$63.20M
Operating Exp
$108.77M
Operating Income
$89.32M
EBIT
$89.32M
Pretax Income
$93.27M
Net Income
$75.43M
EPS (Diluted)
1.28
Price & Volume History
Loading chart…
Recent News
Harmony Biosciences Holdings Insider Sold Shares Worth $1,453,169, According to a Recent SEC Filing
MT Newswires · Sep 9, 2026 9:17 PM
Editas (EDIT) Up 6.2% Since Last Earnings Report: Can It Continue?
Zacks · Sep 4, 2026 3:30 PM
Why Is Harmony Biosciences (HRMY) Up 12.1% Since Last Earnings Report?
Zacks · Sep 3, 2026 3:30 PM
Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress
GlobeNewswire · Sep 3, 2026 12:05 PM
Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference
GlobeNewswire · Aug 27, 2026 12:05 PM
Intuit downgraded, SolarEdge upgraded: Wall Street's top analyst calls
The Fly · Aug 26, 2026 1:41 PM
Wolfe Initiates Harmony Biosciences at Outperform With $60 Price Target
MT Newswires · Aug 26, 2026 11:29 AM
Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline
MarketBeat · Aug 14, 2026 2:04 PM
Harmony Biosciences (HRMY) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 11, 2026 5:29 PM
ANIP Tops Q2 Earnings, Stock Down on Cortrophin Sales View Cut
Zacks · Aug 10, 2026 5:05 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See HRMY's money flow as a full page
Social Sentiment
No Reddit posts found for HRMY.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.